This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Argos Therapeutics, Inc.. Active years: 2011-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2018
Title: Detlef Dieckmann: Innovator in Regulatory T Cell Research
Introduction
Detlef Dieckmann is a notable inventor based in Uttenreuth, Germany. He has made significant contributions to the field of immunology, particularly in the area of regulatory T cells. With a total of four patents to his name, Dieckmann's work has the potential to impact therapeutic approaches in various medical conditions.
Latest Patents
Dieckmann's latest patents focus on the development and application of human CD4CD25T cells. One of his inventions provides methods for expanding these cells and utilizing them as regulatory agents. Another patent details the production of CD4CD25T cells and Tr1-like regulatory T cells, which are essential for regulatory purposes in immunotherapy.
Career Highlights
Dieckmann is currently associated with Argos Therapeutics, Inc., where he continues to advance his research in the field. His work has garnered attention for its innovative approaches to manipulating immune responses, which could lead to breakthroughs in treating autoimmune diseases and enhancing transplant acceptance.
Collaborations
Dieckmann collaborates with Gerold Schuler, further enriching his research endeavors and expanding the scope of their work in regulatory T cell applications.
Conclusion
Detlef Dieckmann's contributions to the field of immunology through his patents and research at Argos Therapeutics, Inc. highlight his role as a key innovator in regulatory T cell research. His work promises to pave the way for new therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile